Gmcsf and disease progression Patient Reports February 11, 2012

Gmcsf Side Effects Report #5254775-2
Gmcsf side effect was reported by a Health Professional from UNITED STATES on Mar 05, 2007. Male patient was diagnosed with prostate cancer  and was treated with Gmcsf. After drug was administered, patient experienced the following side effects: disease progression, muscular weakness, oedema peripheral. Gmcsf dosage: 250MG/M2 QD X14 SQ. Patient was hospitalized. Patient recovered.

Gmcsf Side Effects Report #5927431-2
Gmcsf side effect was reported by a Health Professional from UNITED STATES on Oct 22, 2008. Male patient was diagnosed with prostate cancer  and was treated with Gmcsf. After drug was administered, patient experienced the following side effects: asthenia, dehydration, disease progression, fatigue, urinary tract infection . Gmcsf dosage: 250MG/M2 QD X 14 DAYS FOLLOWED BY 14 DAYS OF REST SQ OFF STUDY 10/3/08. During the same period patient was treated with ZETIA, NEXIUM, TOPROL, LIPITOR, ISOSORBIDE, FOLIC ACID, ALTACE, NORVASC. Patient was hospitalized. Patient recovered.